H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on UroGen Pharma to $23 from $26 and keeps a Buy rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on URGN:
H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on UroGen Pharma to $23 from $26 and keeps a Buy rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on URGN: